|
3'-Phosphoadenosine-5'-phosphosulfate (500 ug) |
ES019 |
500 ug |
R&D SYSTEMS |
|
|
|
|
Ac-Arg-Gly-Lys(Ac)-AMC Fluorogenic Peptide Substrate (5 MG) |
ES016 |
5 MG |
R&D SYSTEMS |
|
|
|
|
ApoStat Intracellular Caspase Detection (FITC-VAD-FMK) (100 Tests) |
FMK012 |
100 Tests |
R&D SYSTEMS |
|
|
|
|
Biotinylated Alkyne (500 ug) |
ES100-500 |
500 ug |
R&D SYSTEMS |
|
|
|
|
Boc-QAR-AMC Fluorogenic Peptide Substrate (10 MG) |
ES014 |
10 MG |
R&D SYSTEMS |
|
|
|
|
Boc-VPR-AMC Fluorogenic Peptide Substrate (20 MG) |
ES011 |
20 MG |
R&D SYSTEMS |
|
|
|
|
Caspase Inhibitor Control Z-FA-FMK (5 MG) |
FMKC01 |
5 MG |
R&D SYSTEMS |
|
|
|
|
Caspase-1/ICE Inhibitor Z-WEHD-FMK (1 MG) |
FMK002 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Caspase-10 Inhibitor Z-AEVD-FMK (1 MG) |
FMK009 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Caspase-12 Inhibitor Z-ATAD-FMK (1 MG) |
FMK013 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Caspase-2 Inhibitor Z-VDVAD-FMK (1 MG) |
FMK003 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Caspase-3 Inhibitor Z-DEVD-FMK (1 MG) |
FMK004 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Caspase-4 Inhibitor Z-YVAD-FMK (1 MG) |
FMK005 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Caspase-6 Inhibitor Z-VEID-FMK (1 MG) |
FMK006 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Caspase-8 Inhibitor Z-IETD-FMK (1 MG) |
FMK007 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Caspase-9 Inhibitor Z-LEHD-FMK (1 MG) |
FMK008 |
1 MG |
R&D SYSTEMS |
|
|
|
|
CMP-Azido-Sialic Acid (100 ug) |
ES102-100 |
100 ug |
R&D SYSTEMS |
|
|
|
|
CMP-C9-Biotin-Sialic Acid (50 ug) |
ES201-050 |
50 ug |
R&D SYSTEMS |
|
|
|
|
CMP-Cy3-Sialic Acid (50 ug) |
ES402-050 |
50 ug |
R&D SYSTEMS |
|
|
|
|
CMP-Cy5-Sialic Acid (50 ug) |
ES302-050 |
50 ug |
R&D SYSTEMS |
|
|
|
|
DLDVPIPGRFDRRVS(PO3)VAAE Ser/Thr Phosphatase Substrate I (1 MG) |
ES012 |
1 MG |
R&D SYSTEMS |
|
|
|
|
GDP-Azido-Fucose (100 ug) |
ES101-100 |
100 ug |
R&D SYSTEMS |
|
|
|
|
GDP-Biotin-Fucose (25 ug) |
ES202-025 |
25 ug |
R&D SYSTEMS |
|
|
|
|
GDP-Cy3-Fucose (20 ug) |
ES401-020 |
20 ug |
R&D SYSTEMS |
|
|
|
|
GDP-Cy5-Fucose (10 ug) |
ES301-010 |
10 ug |
R&D SYSTEMS |
|
|
|
|
H-Met-Gly-Pro-AMC Fluorogenic Peptide Substrate (5 MG) |
ES017 |
5 MG |
R&D SYSTEMS |
|
|
|
|
Mca-KPLGL-Dpa-AR-NH2 Fluorogenic Peptide Substrate (1 MG) |
ES010 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Mca-PLAQAV-Dpa-RSSSR-NH2 Fluorogenic Peptide Substrate (1 MG) |
ES003 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Mca-PLGL-Dpa-AR-NH2 Fluorogenic MMP Substrate (1 MG) |
ES001 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Mca-RPKPVE-Nval-WRK(Dnp)-NH2 Fluorogenic MMP Substrate (1 MG) |
ES002 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Mca-RPPGFSAFK(Dnp)-OH Fluorogenic Peptide Substrate (1 MG) |
ES005 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Mca-SEVNLDAEFRK(Dnp)RR-NH2 Fluorogenic Peptide Substrate (1 MG) |
ES004 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Mca-YVADAPK(Dnp)-OH Fluorogenic Peptide Substrate (1 MG) |
ES007 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Pan Caspase Inhibitor Z-VAD-FMK (1 MG) |
FMK001 |
1 MG |
R&D SYSTEMS |
|
|
|
|
Pan Caspase Inhibitor Z-VKD-FMK Biotinylated (0.5 MG) |
FMK011 |
0.5 MG |
R&D SYSTEMS |
|
|
|
|
pERTKR-AMC Fluorogenic Peptide Substrate (10 MG) |
ES013 |
10 MG |
R&D SYSTEMS |
|
|
|
|
Tyrosine Phosphatase Substrate I, DADEY(PO3)LIPQQG (1 MG) |
ES006 |
1 MG |
R&D SYSTEMS |
|
|
|
|
UDP-Azido-GalNAc (100 ug) |
ES103-100 |
100 ug |
R&D SYSTEMS |
|
|
|
|
UDP-Azido-GlcNAc (100 ug) |
ES104-100 |
100 ug |
R&D SYSTEMS |
|
|
|
|
Z-FR-AMC Fluorogenic Peptide Substrate (50 MG) |
ES009 |
50 MG |
R&D SYSTEMS |
|
|
|
|
Z-LR-AMC Fluorogenic Peptide Substrate (10 MG) |
ES008 |
10 MG |
R&D SYSTEMS |
|
|
|